204 related articles for article (PubMed ID: 24447772)
21. Efficacy of COX-2 inhibitors in controlling inflammation and capsular opacification after phacoemulsification cataract removal.
Brookshire HL; English RV; Nadelstein B; Weigt AK; Gift BW; Gilger BC
Vet Ophthalmol; 2015 May; 18(3):175-85. PubMed ID: 24636042
[TBL] [Abstract][Full Text] [Related]
22. Trypan blue injection into the capsular bag during phacoemulsification: initial postoperative posterior capsule opacification results.
Sharma P; Panwar M
J Cataract Refract Surg; 2013 May; 39(5):699-704. PubMed ID: 23499069
[TBL] [Abstract][Full Text] [Related]
23. Expression of Dominant Negative K6W-Ubiquitin in the Lens Epithelium via an Adenoviral Vector Delays Posterior Capsule Opacification in a Rabbit Model.
Bao X; Hou M; Peng R; Luo F; Wu M
Curr Mol Med; 2017; 17(2):160-168. PubMed ID: 28429670
[TBL] [Abstract][Full Text] [Related]
24. Lens epithelial cell proliferation in human posterior capsule opacification specimens.
Rakic JM; Galand A; Vrensen GF
Exp Eye Res; 2000 Nov; 71(5):489-94. PubMed ID: 11040084
[TBL] [Abstract][Full Text] [Related]
25. The inhibition of lens epithelial cell migration by a discontinuous capsular bend created by a band-shaped circular loop or a capsule-bending ring.
Nishi O; Nishi K; Mano C; Ichihara M; Honda T
Ophthalmic Surg Lasers; 1998 Feb; 29(2):119-25. PubMed ID: 9507255
[TBL] [Abstract][Full Text] [Related]
26. EGFR inhibitor Gefitinib attenuates posterior capsule opacification in vitro and in the ex vivo human capsular bag model.
Wertheimer C; Siedlecki J; Kook D; Mayer WJ; Wolf A; Klingenstein A; Kampik A; Eibl-Lindner K
Graefes Arch Clin Exp Ophthalmol; 2015 Mar; 253(3):409-17. PubMed ID: 25471020
[TBL] [Abstract][Full Text] [Related]
27. Cytoskeletal drugs prevent posterior capsular opacification in human lens capsule in vitro.
Sureshkumar J; Haripriya A; Muthukkaruppan V; Kaufman PL; Tian B
Graefes Arch Clin Exp Ophthalmol; 2012 Apr; 250(4):507-14. PubMed ID: 22138731
[TBL] [Abstract][Full Text] [Related]
28. Use of a polylysine-saporin conjugate to prevent posterior capsule opacification.
Bretton RH; Swearingen A; Kash RL; Cooley R
J Cataract Refract Surg; 1999 Jul; 25(7):921-9. PubMed ID: 10404366
[TBL] [Abstract][Full Text] [Related]
29. Pharmacologic prevention of posterior capsule opacification: in vitro effects of preservative-free lidocaine 1% on lens epithelial cells.
Vargas LG; Escobar-Gomez M; Apple DJ; Hoddinott DS; Schmidbauer JM
J Cataract Refract Surg; 2003 Aug; 29(8):1585-92. PubMed ID: 12954311
[TBL] [Abstract][Full Text] [Related]
30. Cyclosporin effectively inhibits posterior capsule opacification after phacoemulsification in rabbits: a preliminary study.
Totan Y; Yağci R; Erdurmuş M; Bayrak R; Hepşen IF
Clin Exp Ophthalmol; 2008; 36(1):62-6. PubMed ID: 18290955
[TBL] [Abstract][Full Text] [Related]
31. Effect of cortical cleaving hydrodissection on posterior capsule opacification in age-related nuclear cataract.
Vasavada AR; Dholakia SA; Raj SM; Singh R
J Cataract Refract Surg; 2006 Jul; 32(7):1196-200. PubMed ID: 16857509
[TBL] [Abstract][Full Text] [Related]
32. [Histopathological study of the effect of preservative-free 1% lidocaine on rabbit lens epithelial cells].
Duan HX; Guan HJ; Yang L; Xu XD; Zou MB
Zhonghua Yan Ke Za Zhi; 2007 Oct; 43(10):917-21. PubMed ID: 18201530
[TBL] [Abstract][Full Text] [Related]
33. Induction of posterior capsule opacification by hyaluronic acid in an ex vivo model.
Chandler HL; Haeussler DJ; Gemensky-Metzler AJ; Wilkie DA; Lutz EA
Invest Ophthalmol Vis Sci; 2012 Apr; 53(4):1835-45. PubMed ID: 22408013
[TBL] [Abstract][Full Text] [Related]
34. Prevention of posterior capsule opacification by the induction of therapeutic apoptosis of residual lens cells.
Malecaze F; Decha A; Serre B; Penary M; Duboue M; Berg D; Levade T; Lubsen NH; Kremer EJ; Couderc B
Gene Ther; 2006 Mar; 13(5):440-8. PubMed ID: 16251995
[TBL] [Abstract][Full Text] [Related]
35. Capsular adhesion to intraocular lens in highly myopic eyes evaluated in vivo using ultralong-scan-depth optical coherence tomography.
Zhao Y; Li J; Lu W; Chang P; Lu P; Yu F; Xing X; Ding X; Lu F; Zhao Y
Am J Ophthalmol; 2013 Mar; 155(3):484-491.e1. PubMed ID: 23218694
[TBL] [Abstract][Full Text] [Related]
36. Determination of trypan blue efficacy in the mitigation of ex vivo canine PCO formation.
Brash BM; Gemensky-Metzler AJ; Wilkie DA; Miller EJ; Chandler HL
Vet Ophthalmol; 2019 Nov; 22(6):902-909. PubMed ID: 30942514
[TBL] [Abstract][Full Text] [Related]
37. Anterior and posterior capsular opacification with the Tecnis ZCB00 and AcrySof SA60AT IOLs: a randomised intraindividual comparison.
Kahraman G; Schrittwieser H; Walch M; Storch F; Nigl K; Ferdinaro C; Amon M
Br J Ophthalmol; 2014 Jul; 98(7):905-9. PubMed ID: 24368628
[TBL] [Abstract][Full Text] [Related]
38. Effects of grape seed extract, lutein, and fish oil on responses of canine lens epithelial cells in vitro.
Miller EJ; Gemensky-Metzler AJ; Wilkie DA; Wynne RM; Curto EM; Chandler HL
Am J Vet Res; 2018 Jul; 79(7):770-778. PubMed ID: 29943637
[TBL] [Abstract][Full Text] [Related]
39. Capsular tension ring-based in vitro capsule opacification model.
Burger J; Kreutzer T; Alge CS; Strauss RW; Eibl K; Haritoglou C; Neubauer AS; Kampik A; Priglinger SG
J Cataract Refract Surg; 2008 Jul; 34(7):1167-72. PubMed ID: 18571087
[TBL] [Abstract][Full Text] [Related]
40. [Lens fiber differentiation in rats posterior capsule opacification].
Huang YS; Xie LX
Zhonghua Yan Ke Za Zhi; 2007 Mar; 43(3):260-5. PubMed ID: 17605911
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]